B. Coignard
-
- Antibiotic Use and Resistance 20
- Infectious Diseases top 0.5%
- Antimicrobial Resistance in Staphylococcus 11
- Clostridium difficile and Clostridium perfringens research 11
-
- Nosocomial Infections in ICU 14
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 22
- Epidemiology top 1%
- Urinary Tract Infections Management 9
- Microscopic Colitis 7
-
- Bacterial Identification and Susceptibility Testing 13
- Co-authors
- Ed J. KuijperPeet TüllYann Le StratL. Clifford McDonaldErik R. DubberkeTeresa HoranPreeta K. KuttyXiaoyan Song
- Cited by
- Applied Microbiology and BiotechnologyInfectious DiseasesCritical Care and Intensive Care Medicine
- Journals
- Eurosurveillance (14 papers)Infection Control and Hospital Epidemiology (8 papers)Journal of Hospital Infection (4 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
B. Coignard
76 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Applied Microbiology and Biotechnology 522
- Infectious Diseases 2.7k
- Critical Care and Intensive Care Medicine 670
- Molecular Medicine 637
- Epidemiology 2.1k
Countries citing papers authored by B. Coignard
This map shows the geographic impact of B. Coignard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Coignard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Coignard more than expected).
Fields of papers citing papers by B. Coignard
This network shows the impact of papers produced by B. Coignard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Coignard. The network helps show where B. Coignard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside B. Coignard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Nirsevimab Effectiveness Against Cases of Respiratory Syncytial Virus Bronchiolitis Hospitalised in Paediatric Intensive Care Units in France, September 2023–January 2024breakdown → | 2024 | 44 |
| 2 | 2023 | 0 | |
| 3 | 2022 | 26 | |
| 4 | 2022 | 3 | |
| 5 | 2020 | 24 | |
| 6 | 2016 | 43 | |
| 7 | 2015 | 12 | |
| 8 | 2015 | 6 | |
| 9 | 2013 | 54 | |
| 10 | 2011 | 36 | |
| 11 | 2011 | 247 | |
| 12 | 2011 | 5 | |
| 13 | Notification of healthcare-associated infections, France, 2007-2009. | 2010 | 1 |
| 14 | 2010 | 7 | |
| 15 | 2008 | 1 | |
| 16 | 2007 | 13 | |
| 17 | 2006 | 73 | |
| 18 | 2006 | 9 | |
| 19 | 2000 | 9 | |
| 20 | 1998 | 14 |
About B. Coignard
B. Coignard is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Critical Care and Intensive Care Medicine, Infectious Diseases and Clinical Biochemistry, having authored 79 papers that have together received 4.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (22 papers), Antibiotic Use and Resistance (20 papers), Nosocomial Infections in ICU (14 papers), Bacterial Identification and Susceptibility Testing (13 papers), Antimicrobial Resistance in Staphylococcus (11 papers), Clostridium difficile and Clostridium perfringens research (11 papers), Urinary Tract Infections Management (9 papers) and Microscopic Colitis (7 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (522 citations), Infectious Diseases (2.7k citations), Critical Care and Intensive Care Medicine (670 citations), Molecular Medicine (637 citations) and Epidemiology (2.1k citations). B. Coignard has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Ed J. Kuijper, Peet Tüll, Yann Le Strat, L. Clifford McDonald, Erik R. Dubberke, Teresa Horan, Preeta K. Kutty, Xiaoyan Song, Françoise Dromer and Olivier Lortholary. Their work appears in journals such as Eurosurveillance, Infection Control and Hospital Epidemiology, Journal of Hospital Infection, Clinical Microbiology and Infection and Emerging infectious diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.